Advertisement
Advertisement

ANRO

ANRO logo

Alto Neuroscience Inc.

22.85
USD
Sponsored
-1.78
-7.23%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

22.89

+0.04
+0.20%

Alto Neuroscience Inc. Profile

About

Alto Neuroscience Inc. is a clinical-stage biopharmaceutical company. Its clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia and other mental health conditions. Alto Neuroscience Inc. is based in LOS ALTOS, Calif.

Info & Links

CEO

Amit Etkin

Headquarters

650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.altoneuroscience.com

Auditor

Deloitte & Touche LLP

Share holders

20

Employees

68

Alto Neuroscience Inc. Statistics

Valuation Measures

Market Capitalization2

802.53M

Enterprise Value

645.03M

Enterprise Value/EBITDA(ttm)

-9.82

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.60

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-47.64%

Return on Invested Capital(ttm)

-41.76%

Return on Assets(ttm)

-37.83%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-65.70M

Net Income Available to Common(ttm)

-63.24M

Diluted EPS(ttm)

-2.18

Share Statistics

Beta (5Y Monthly)

2.01

52-Week Change

864.14%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

31.95M

Dividend Yield

0.00%

Float4

28.35M

% Held by Insiders

11.25%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

176.48M

Total Cash Per Share(mrq)

5.52

Total Debt(mrq)

18.98M

Total Debt/Equity(mrq)

12.56%

Current Ratio(mrq)

15.69%

Quick Ratio(mrq)

15.69%

Book Value Per Share(mrq)

4.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.79

Free Cash Flow(ytd)

-51.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement